Cefurox

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cefurox

What is Cefurox?

Cefurox is a prescription medication belonging to a class of drugs known as cephalosporin antibiotics. Specifically, it is categorized as a second-generation cephalosporin. This medication is used to treat a variety of bacterial infections by interfering with the way bacteria build their protective cell walls.

Mechanism of Action

The active ingredient in Cefurox works by binding to and inhibiting specific proteins within the bacterial cell wall. These proteins are essential for the structural integrity of the bacteria. By disrupting this process, the medication causes the cell wall to weaken and eventually rupture, leading to the elimination of the bacteria causing the infection.

Spectrum of Activity

As a second-generation cephalosporin, Cefurox has a broad spectrum of activity, meaning it is effective against various types of bacteria. It is designed to target both Gram-positive and certain Gram-negative organisms. This makes it a versatile option for addressing different types of localized and systemic bacterial issues.

Common Applications

Cefurox is typically utilized in the management of several types of bacterial conditions, including:

  • Respiratory Tract Infections: Such as those affecting the throat, sinuses, or lungs.
  • Urinary Tract Infections: Addressing bacteria present in the bladder or kidneys.
  • Skin and Soft Tissue Infections: Treating bacterial growth in skin layers or underlying tissues.
  • Ear Infections: Often used for middle ear inflammations caused by susceptible bacteria.

Because it is an antibiotic, Cefurox is only effective against infections caused by bacteria; it does not have any effect on viral infections, such as the common cold or the flu.

Regulatory References

  1. (StatPearls - NIH)

What side effects are possible with Cefurox?

Possible Side Effects and Safety Information

The safety profile for Cefuroxime is systematically defined by classifying adverse reactions according to their official frequency and the affected body system, as documented by regulatory authorities. The adverse reactions are grouped into System-Organ Classes (SOCs), highlighting impacts on gastrointestinal, nervous, and blood and lymphatic systems.

Frequency-Classified Adverse Reactions

The table below outlines the reactions classified by frequency in official regulatory documents:

Classification Examples of Documented Reactions
Common (ge 1/100 to < 1/10) Diarrhoea, Nausea, Headache, Dizziness, Transient increases of hepatic enzyme levels, Candida overgrowth
Uncommon (ge 1/1,000 to < 1/100) Vomiting, Skin rashes, Leukopenia, Thrombocytopenia, Positive Coombs' test

Serious Safety Considerations

The official labeling documents rare but clinically significant adverse reactions, including Anaphylaxis and other severe hypersensitivity reactions, Haemolytic Anaemia, and Seizures. Of particular note is the risk of Clostridioides difficile-Associated Diarrhea (CDAD), which may occur during or up to two months following the completion of treatment.

Safety Restrictions and Patterns

Cefuroxime is contraindicated in individuals with a known hypersensitivity to the drug, any component of the formulation, or to other beta-lactam antibacterial drugs (e.g., penicillins or cephalosporins). Specific safety notes exist for certain populations, such as the requirement for cautious use in patients with Renal Impairment. Additionally, the official label specifies the timing for certain reactions, such as the Jarisch-Herxheimer reaction occurring specifically during the treatment of Lyme disease.

Overdose and Emergency Response

Cefuroxime Overdose is primarily associated with serious Central Nervous System (CNS) manifestations. Documented presentations of overdose start with cerebral irritation and convulsions (seizures). Regulatory labeling also reports potential severe neurological sequelae, including encephalopathy and coma. The official overdose profile clarifies that manifestations range from less severe signs to outcomes classified as potentially life-threatening.


When to Seek Immediate Medical Help

Official guidance requires that immediate medical attention be sought if severe symptoms are suspected. You must immediately call emergency services (such as 911) if the affected person has collapsed, had a seizure, has trouble breathing, or can't be awakened. Contacting a poison control helpline is a required step for obtaining expert overdose guidance.


Management and Specific Considerations

No specific antidote is known for Cefuroxime overdose. Management is restricted to supportive and symptomatic treatment under medical supervision. Regulatory documents confirm that the drug’s serum levels can be effectively reduced by procedures such as hemodialysis and peritoneal dialysis. A specific consideration is noted for individuals with renal impairment, as overdose symptoms may occur if the usual dose is not appropriately reduced due to compromised kidney function.

Therapeutic Uses of Cefurox

What Cefurox Treats: Main Uses and Benefits

The purpose of Cefuroxime is to provide targeted therapeutic support by addressing conditions that involve inflammatory or irritative processes, which contributes to easing the overall symptom load. The medication is commonly used across a range of clinical presentations where symptoms cluster into patterns requiring supportive management.


Acute Infections and Symptomatic Relief

Cefuroxime is commonly used across conditions presenting with acute episodes affecting the respiratory tract and ENT system, uncomplicated skin infections, and urinary tract infections (UTIs). It is applied when symptoms create noticeable physiological strain such as fever, ear pain, sore throat, painful urination, or skin redness and tenderness. In these situations, addressing the conditions provides supportive relief when symptoms interfere with routine activities and assists in managing acute symptomatic episodes.


Clinical Focus and Patient Benefit

The drug may be part of symptomatic management in clinical settings involving conditions associated with acute or disruptive episodes. These conditions presenting with systemic or localized discomfort include acute otitis media, sinusitis, pneumonia, cellulitis, and early Lyme disease. In these cases, Cefuroxime provides support that helps ease the overall symptom burden and supports the patient during difficult episodes by easing distress.

Quick Fact: Relief for Localized Discomfort Cefuroxime is relevant for managing symptoms related to inflammatory or irritative states, such as earache and throat pain, where symptom management assists with maintaining functional stability.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Cefuroxime (Cefurox) — official regulatory information


Eligibility Scope

Classification Populations and Conditions
Contraindicated (Must NOT use) Known hypersensitivity to Cefuroxime or any cephalosporin antibiotic. History of severe allergic reaction (e.g., anaphylaxis) to any other beta-lactam antibiotic, including penicillins.
Use Restricted/Caution Patients with impaired renal function (dosage adjustment required). History of gastrointestinal disease, especially colitis or severe diarrhea. Use of oral suspension in patients with Phenylketonuria (PKU) (contains phenylalanine).
Age Limitations Infants younger than 3 months of age: safety and efficacy are not established for the oral suspension. The tablet form is generally indicated for children 13 years and older.
Physiological Status Pregnancy: Use is permitted only if clearly needed and the benefit outweighs the potential risk (limited data). Breastfeeding: Use requires weighing the benefit to the mother against the risk to the child, as the drug passes into breast milk.

Eligibility Classifications (High-Level)

The official regulatory profile defines eligibility through absolute contraindications related to allergic status and conditional use warnings based on patient health status. The most critical restriction is a known cephalosporin or severe beta-lactam allergy. Use is also explicitly limited by age and organ function, requiring a reduction in dosage for patients with severe renal impairment to prevent accumulation and potential neurotoxicity.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information describes specific patterns in which Cefuroxime (Cefuroxime axetil) interacts with other substances, primarily affecting drug concentrations and the effectiveness of co-administered medicines.

Category
Exposure Modification (Clearance)
Transporter Mechanism
Pharmacodynamic Effect
Diagnostic Interference

Official Interaction Statements:

  • Coadministration with Probenecid is not recommended by regulatory authorities. This is due to an interaction that inhibits renal tubular secretion, resulting in a documented increase in Cefuroxime systemic exposure (AUC and Cmax).
  • Drugs that reduce gastric acidity, including H2-antagonists and Proton Pump Inhibitors (PPIs), are documented to lower the oral bioavailability of Cefuroxime axetil. For antacids containing aluminum or magnesium, a timing separation is required, meaning the antibiotic should be administered at least one hour before or two hours after the antacid.
  • An interaction is noted with Oral Contraceptives that contain estrogen/progesterone. Cefuroxime may affect gut flora, leading to lowered estrogen reabsorption and reduced efficacy of the contraceptive medicine.
  • Food consumption with the oral prodrug is documented to increase the absorption and overall bioavailability of Cefuroxime axetil.
  • Cefuroxime is officially documented to cause a false-positive result with copper reduction tests for urine glucose and a false-negative result with ferricyanide tests for blood/plasma glucose.

Connection to the Overall Interaction Profile

Regulatory documents define the product's interaction structure primarily through two pharmacokinetic domains—renal clearance modification and oral absorption dependence on gastric acidity—coupled with a specific pharmacodynamic interaction affecting hormonal contraceptives. This profile also incorporates procedural constraints, such as the timing separation requirement for certain antacids and documented interference with common laboratory testing reagents.

Mechanism of Action

How Cefurox works

Cefuroxime's mechanism involves targeting structures in the bacterial cell wall synthesis pathway, resulting in the inhibition of peptidoglycan cross-linking.


Cell Wall Synthesis Inhibition: beta-Lactam Domain

This action involves the drug modifying early molecular steps by mimicking the structure of D-Ala-D-Ala, the natural substrate for penicillin-binding proteins (PBPs), bacterial enzymes essential for the final cross-linking step of peptidoglycan synthesis. Engaging this mechanism blocks the formation of the rigid cell wall.


Targeting Penicillin-Binding Proteins (PBPs)

Cefuroxime initiates a suppression sequence by covalently binding to and inactivating bacterial PBPs, primarily PBP3, which are crucial for constructing the cell envelope. This PBP modulation prevents necessary cross-links from forming, resulting in reduced structural integrity of the bacterial cell wall.


Cell Lysis and Structural Breakdown

As a downstream cascade, the weakened, incomplete cell wall structure activates bacterial autolytic enzymes (autolysins). This initiates bacterial autolysis, leading to osmotic instability and breakdown of the cellular structure, a process called lysis.

Dosage and Administration Information

Cefurox (cefuroxime) is an antibiotic prescribed to treat a range of bacterial infections, and it must be taken exactly as directed by your healthcare professional.

General Administration

  • Do not stop taking Cefurox until the full prescribed course is completed, even if your symptoms improve before the medicine is finished. Stopping early may cause the infection to return and may lead to antibiotic-resistant bacteria.
  • Do not skip doses. If a dose is missed, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue your regular schedule. Do not double the dose.
  • Cefuroxime is not effective against viral infections such as the common cold or flu.

Oral Forms (Tablets and Suspension)

Form Administration Guidance
Tablet May be taken with or without food. Swallow the tablet whole. Do not crush, break, or chew, as this can result in a strong, bitter taste.
Oral Suspension (Liquid) Must be taken with food for better absorption. Shake the liquid well before each use. Use the provided measuring device (spoon, syringe, or cup) to ensure an accurate dose.

Storage

  • Store Cefurox tablets at room temperature, away from excess heat and moisture.
  • Store the reconstituted oral suspension in the refrigerator. Any unused suspension must be discarded after 10 days.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cefuroxime

This section provides a summary of the official clinical research and study base for Cefuroxime, detailing the types of research conducted, the outcomes that were measured, and the recognized limitations, strictly without offering clinical advice or recommendations.


Research Evidence for Key Infection Types

The structure of the clinical evaluation focuses on Randomized Controlled Trials (RCTs) and systematic reviews. For Acute Otitis Media (AOM), studies explored how symptoms change over time in pediatric patients, specifically tracking measured symptom change and the frequency of incomplete symptom resolution.

For Acute Maxillary Sinusitis, research included controlled clinical trials measuring investigator-defined clinical success based on patient-reported outcomes. Some trials described patterns of minimal measurable difference between Cefuroxime and placebo for certain populations, an observation noted in the context of the condition's high rate of spontaneous resolution.

Research for uncomplicated skin, urinary tract, and lower respiratory tract infections was typically evaluated in active-controlled clinical trials. Findings were consistent with the established use of the drug, monitoring outcomes like bacteriologic eradication and clinical symptom resolution.

Research Evidence for Early Lyme Disease

Controlled clinical studies investigated Cefuroxime for Early Lyme Disease (Erythema Migrans). Research describes measured rates of investigator-defined clinical success (symptom change of the rash and systemic signs) at the end of the treatment period. Follow-up studies monitored the long-term absence of late-stage disease manifestations, such as neurological symptoms, for up to one year post-treatment. Sample sizes were modest in some pivotal trials, and certainty remains low regarding subtle long-term differences between standard treatments.


Current Evidence Gaps and Uncertainties

The research highlights that the long-term effects are not fully established for many indications, as follow-up durations were typically limited to a few weeks or months post-treatment. Evidence quality varies across studies, and findings are affected by the use of subjective measures, such as patient-reported outcomes. New research is needed to provide data that fully reflects current antibiotic resistance patterns.

Key Studies & References

  1. Comparative Study of Cefuroxime Axetil Versus Amoxicillin in Children With Early Lyme Disease
  2. Management (erythema migrans) - NCBI Bookshelf (Review on Lyme Disease treatments)

Frequently Asked Questions (FAQ)

Common questions about Cefurox (FAQ)


Q: What is Cefurox used for besides the main things?

Regulatory documents indicate that Cefuroxime is officially used to treat a variety of bacterial infections. These include infections of the throat (pharyngitis/tonsillitis), ear (acute bacterial otitis media), sinuses, and uncomplicated gonorrhea, in addition to its use for respiratory, skin, and urinary tract infections, and early Lyme disease.


Q: Can Cefurox be taken by older adults?

Official product information notes that Cefuroxime is generally used in older adults, and age alone does not typically require a dosage change. However, because the body primarily eliminates this medicine through the kidneys, a modification to the prescribed dose may be determined necessary by a healthcare professional to account for changes in elimination.


Q: Are there any food or drinks I should avoid while on Cefurox?

The absorption of oral Cefuroxime is known to be affected by food and by medicines that reduce stomach acid. Although alcohol is not listed as an absolute contraindication, official warnings note that caution with alcohol consumption is sometimes recommended due to the potential for a rare reaction when combined with certain antibiotics.


Q: How long does Cefurox stay in your system after stopping it?

According to official pharmacokinetics data, Cefuroxime has a mean serum elimination half-life of about 1.2 to 1.5 hours in adults with normal kidney function. This means it takes approximately that long for half of the medicine to be cleared from the bloodstream. For individuals with reduced kidney function, this time is significantly longer.


Q: Is Cefurox known to cause anxiety or mood changes?

Anxiety and mood changes, such as nervousness or confusion, are not typically listed as common side effects of Cefuroxime in the official product information. However, very rare occurrences of nervous system disorders, including restlessness, nervousness, and confusion, have been reported in post-marketing surveillance.


Q: Can Cefurox be used to prevent infections?

Regulatory documents state that the injectable form of Cefuroxime is specifically approved for surgical prophylaxis (prevention of infection) in certain operations. Official regulatory documents do not list the oral forms for general infection prevention.


Q: Why is Cefurox sometimes given before surgery?

Cefuroxime, specifically the injectable formulation, is indicated for use before certain surgical procedures. According to official documents, this is done to help prevent the development of potential post-operative bacterial infections at the surgical site.


Q: Do official patient leaflets mention interactions with herbal supplements?

While the core regulatory interaction sections usually focus on prescription and non-prescription medicines, official patient counseling information often advises broad disclosure. It recommends telling your healthcare professional about all prescription and nonprescription medications, vitamins, nutritional supplements, and any herbal products you may be taking.


Q: Is Cefurox a strong antibiotic?

Regulatory documents classify Cefuroxime as a second-generation cephalosporin antibiotic, which means it is a bactericidal agent that actively kills bacteria. It is described as stable against many bacterial beta-lactamase enzymes, which is associated with an activity profile against a broader range of bacteria.


Q: What are the most common side effects of Cefurox that people mention online?

The most common side effects officially documented in clinical trials (occurring in 1/100 to less than 1/10 patients) include Candida overgrowth, headache, dizziness, and gastrointestinal disturbances like diarrhoea and nausea. These official classifications help patients and doctors understand the typical safety profile.


Q: Is Cefurox a penicillin type of antibiotic?

No, Cefuroxime is classified as a cephalosporin antibiotic. However, both cephalosporins and penicillins belong to the same large group of drugs called beta-lactam antimicrobials. A known severe allergic reaction to penicillins is an official contraindication for using Cefuroxime.


Q: What should I do if Cefurox doesn't seem to be working?

Official patient counseling guidance emphasizes that antibiotics should only be used for bacterial infections. If the symptoms of a bacterial infection do not improve or begin to worsen while taking Cefuroxime, official guidance emphasizes that the lack of improvement or worsening of symptoms should be discussed with a healthcare professional.


Q: Does Cefurox make you tired or dizzy?

Official product information lists dizziness as a common side effect (occurring in 1/100 to less than 1/10 patients). While generalized tiredness is not typically listed as a common effect, it is possible for some people to experience less common nervous system effects.


Q: What is the difference between Cefurox and amoxicillin?

Cefuroxime is a second-generation cephalosporin, while amoxicillin belongs to the penicillin class. Official regulatory information describes Cefuroxime as having enhanced stability against certain bacterial enzymes called beta-lactamases, giving it a different range of activity compared to some older antibiotics.


Q: Is Cefurox considered safe during pregnancy based on official classification?

The official classification by the FDA designates Cefuroxime as Pregnancy Category B. This means that animal studies have not shown harm to the fetus, but there are no adequate studies in pregnant women. The conditions of use, according to official guidance, are permitted only if the drug is clearly needed and the potential benefit outweighs the risk.


Q: What is the risk of an allergic reaction to Cefurox?

The most important risk is hypersensitivity, or allergic reactions. Official labeling warns that serious and sometimes fatal hypersensitivity reactions (like anaphylaxis) have been reported with all beta-lactam antibiotics. Less severe reactions, such as skin rashes and hives, are listed as common or uncommon adverse effects.


Q: Is Cefurox approved for children?

Yes, Cefuroxime is approved for use in children. The oral suspension is generally indicated for children starting from 3 months of age for specific infections. The tablet form typically has age restrictions and is indicated for use in older children (e.g., 13 years and older) and adults.


Q: Does taking Cefurox affect your gut bacteria?

Regulatory warnings state that Cefuroxime may disrupt the natural balance of microorganisms, which may lead to the overgrowth of non-susceptible organisms, including Candida (yeast infection). It is also associated with the risk of C. difficile-associated diarrhea (CDAD), which is a known issue from antibiotic-related gut flora changes.


Q: What are the main risks associated with long-term use of Cefurox?

Regulatory documents caution that prolonged use of Cefuroxime may create a risk for the overgrowth of non-susceptible organisms, such as fungi like Candida and the bacterium Clostridioides difficile. Regulatory documents indicate that if this overgrowth occurs, interruption of treatment may be determined necessary.


Q: What should I do if I vomit shortly after taking Cefurox?

Vomiting is listed as an uncommon side effect. Because the oral medication must be absorbed by the body to be effective, vomiting shortly after administration may result in incomplete absorption. Official product information provides instructions for dealing with a missed dose but does not provide specific guidance for action to take after vomiting shortly after administration.


Q: What does the evidence say about Cefurox's activity against resistant bacteria?

Official regulatory texts describe Cefuroxime as being stable against many bacterial enzymes known as beta-lactamases, particularly plasmid-mediated ones. This stability is key to its activity against many common pathogens that have developed resistance to other antibiotics.


Q: Can you take Cefurox if you have diabetes?

Diabetes is not listed as a contraindication in regulatory documents. However, official information notes that Cefuroxime can interfere with some specific glucose tests, such as copper reduction tests for urine sugar. This is an important consideration for people monitoring their blood sugar levels.


Q: What are the differences in how Cefurox is used in adults versus children?

Official documents note differences in approved formulations and age. The oral suspension (liquid) is often indicated for younger children, while the tablet form is typically for older children and adults. Specific age limits and indications apply to different forms.


Q: What information is available about Cefurox's safety profile from clinical trials?

The safety profile is established through clinical trials and ongoing surveillance. This information is summarized in official documents by classifying side effects based on how frequently they occurred, such as Common (headache, diarrhoea) and Uncommon (vomiting, skin rashes), alongside listing Serious events like anaphylaxis.

How should Cefurox be stored and disposed of?

Official Storage and Disposal Requirements

Cefuroxime (Cefurox) must be stored and handled according to specific regulatory guidelines to maintain potency and ensure environmental safety.

Formulation Required Storage Condition Stability/Time Limit
Oral Tablets (Unopened) Store at controlled Room Temperature (20 C to 25 C). Keep in original, tightly closed container.
Oral Suspension (Reconstituted) Must be stored in the refrigerator (2 C to 8 C). Discard any unused portion after 10 days.

Handling and Protection: Do not freeze any Cefuroxime formulation. The medication must be kept out of the reach of children and protected from excess heat, moisture, and light.

Disposal: Unused or expired medication must not be disposed of in household trash or poured down a sink or toilet. Disposal should follow official local and national environmental regulations, often through an approved drug take-back program or pharmacy.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cefurox found in:

A-Z Index: